BioSig Technologies, Inc. (BSGM)
NASDAQ: BSGM · Real-Time Price · USD
6.70
+0.20 (3.08%)
At close: Jun 20, 2025, 4:00 PM
6.65
-0.05 (-0.75%)
After-hours: Jun 20, 2025, 7:57 PM EDT

Company Description

BioSig Technologies, Inc., a medical technology company, provides digital signal processing technology platform services in the United States.

The company offers PURE EP Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias.

It has a research agreement with Mayo Foundation with the right to sublicense for patent applications in the fields of signal processing, physiologic recording, electrophysiology recording, electrophysiology software, and autonomics to develop, make, and offer for sale.

The company also designs and develops an online platform for real-world asset (RWA) tokenization. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Los Angeles, California.

BioSig Technologies, Inc.
BioSig Technologies logo
Country United States
Founded 2009
Industry Medical Devices
Sector Healthcare
Employees 5
CEO Karl McPhie

Contact Details

Address:
12424 Wilshire Blvd, Suite 745
Los Angeles, California 90025
United States
Phone 203 409 5444
Website biosig.com

Stock Details

Ticker Symbol BSGM
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001530766
CUSIP Number 09073N201
ISIN Number US09073N3008
Employer ID 26-4333375
SIC Code 3845

Key Executives

Name Position
Karl Henry McPhie Chief Executive Officer and Director
Ferdinand Groenewald Interim Chief Financial Officer and Principal Accounting Officer
Mitchell Williams CFA Chief Investment Officer
Lora Mikolaitis Chief Administrative Officer

Latest SEC Filings

Date Type Title
May 30, 2025 8-K Current Report
May 27, 2025 8-K Current Report
May 19, 2025 10-Q Quarterly Report
May 15, 2025 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
May 15, 2025 8-K Current Report
May 5, 2025 8-K Current Report
Apr 30, 2025 8-K Current Report
Apr 29, 2025 8-K Current Report
Apr 15, 2025 8-K Current Report
Apr 15, 2025 10-K Annual Report